American Society of Clinical Oncology

SHERPA: White

People

  1. Ku
    Ku
  2. Schultz
    Schultz
  3. Ilson
    Ilson
  4. Solit
    Solit
  5. Kelsen
    Kelsen
  6. Janjigian
    Janjigian
  7. Maron
    Maron
  8. Chatila
    Chatila
  9. Tang
    Tang
  10. Capanu
    Capanu

Groups

  1. Computational Oncology Service (16)
  2. Department of Medicine (16)
  3. Epidemiology and Biostatistics (16)
  4. GSK Faculty (16)
  5. Gastrointestinal Oncology Service (16)
  6. Hematologic Malignancies, Division of (16)
  7. Human Oncology and Pathogenesis Program (16)
  8. Solid Tumor Oncology Division (16)
  9. Center for Pancreatic Cancer Research (13)
  10. Genitourinary Oncology Service (10)
Search Within
  1. "Computational Oncology Service"
  2. "Geoffrey Ku"
Formats
  1. Meeting Abstract (16)
Groups
  1. Computational Oncology Service (16)
  2. Department of Medicine (16)
  3. Epidemiology and Biostatistics (16)
  4. GSK Faculty (16)
  5. Gastrointestinal Oncology Service (16)
  6. Hematologic Malignancies, Division of (16)

More Groups

People
  1. Geoffrey Ku (16)
  2. Nikolaus Schultz (16)
  3. David Ilson (15)
  4. Yelena Janjigian (15)
  5. David Solit (10)
  6. David Kelsen (9)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (16)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of resistance to trastuzumab deruxtecan (T-DXd) in esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Chou, J. F.; Biachi de Castria, T.; Tang, L. H.; Ilson, D. H.; Ku, G. Y.; Schultz, N.; Capanu, M.; Janjigian, Y. Y.; Maron, S. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Differences in genomic profiles of gastric adenocarcinoma in the US and Japan
    Meeting Abstract

    Nakauchi, M.; Court, C.; Walsh, H. S.; Chatila, W. K.; Shimada, S.; Vardhana, S.; Tang, L. H.; Coit, D. G.; Janjigian, Y. Y.; Maron, S. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Brain metastasis in gastroesophageal adenocarcinoma: Outcomes and molecular features
    Meeting Abstract

    Tsai, C.; Nguyen, B.; Luthra, A.; Chou, J. F.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Nakauchi, M.; Walch, H. S.; Chatila, W. K.; Tran, T.; Vos, E. L.; Sihag, S.; Tang, L. H.; Coit, D. G.; Stadler, Z. K.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
    Meeting Abstract

    Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save